Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Blood|February 26, 2013
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse modelPaolo Sportoletti, Emanuela Varasano, Roberta Rossi, et al.
Blood Advances|January 25, 2020
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trialGiacomo Gianfaldoni, Francesco Mannelli, Tamara Intermesoli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO GroupFrancesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Blood Cancer Journal|November 14, 2020
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07Renato Bassan, Chiara Pavoni, Tamara Intermesoli, et al.
Blood|July 5, 2011
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosisPaola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2016
Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term OutcomeFederico Lussana, Tamara Intermesoli, Francesca Gianni, et al.
Respiratory Medicine and Research|December 6, 2022
One-year mortality in COVID-19 is associated with patients' comorbidities rather than pneumonia severityLuca Novelli, Federico Raimondi, Greta Carioli, et al.
Blood Advances|April 6, 2019
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Tamara Intermesoli, Arianna Masciulli, et al.
Pageof 4